Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSS2000021	美泊利单抗注射液	mepolizumab	Injection	Biological Products	Import Drug Application	2020-07-06	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2021-11-19	view
JXSL2000148	美泊利单抗注射液	mepolizumab	Injection	Biological Products(2.2)	Import Drug Application	2020-09-09	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2020-09-08	view
JXSL2000004	美泊利单抗注射液	mepolizumab	Injection	Biological Products	Import Drug Application	2020-01-18	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2020-01-17	view
JXSL1900136	美泊利单抗注射液	mepolizumab	Injection	Biological Products	Import Drug Application	2019-12-16	GlaxoSmithKline Trading Services Limited	Glaxosmithkline Trading Services Ltd	In Review	2019-12-14	view
JXSB2101115	美泊利单抗注射液	mepolizumab	Injection	Biological Products	Supplementary Application	2021-12-31					view
CXSL2101358	美泊利单抗注射液	mepolizumab	Injection	Biological Products(3.3)	New Drug Application	2021-10-19		Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group			view